CFC
IDXX icon

Coyle Financial Counsel’s Idexx Laboratories IDXX Stock Holding History

Coyle Financial Counsel’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Buy
387
+21
+6% +$13.5K 0.05% 106
2025
Q4 		$248K Buy
+366
New +$249K 0.05% 100

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coyle Financial Counsel's IDXX Position: Q1 2026 in Review

Coyle Financial Counsel increased its Idexx Laboratories (IDXX) stake by 5.7% in Q1 2026, buying an estimated $13.5K and bringing the position to 387 shares worth $217K. The position accounts for 0.05% of the portfolio, ranked #106.

Coyle Financial Counsel first reported a position in IDXX in Q4 2025 and has held it in 2 quarters since. The position peaked at $248K in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Coyle Financial Counsel held 387 shares of Idexx Laboratories worth $217K as of Q1 2026.
  • Coyle Financial Counsel bought 21 Idexx Laboratories shares in Q1 2026, an estimated $13.5K.
  • Idexx Laboratories made up 0.05% of Coyle Financial Counsel's portfolio in Q1 2026, its #106 holding.
  • Coyle Financial Counsel first reported a position in Idexx Laboratories in Q4 2025 and has held it in 2 quarters since.
  • Coyle Financial Counsel's Idexx Laboratories position peaked at $248K in Q4 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Coyle Financial Counsel's 13F filing for Q1 2026, filed 12 May 2026.